NEVVI Medicare utilization intelligence
or

← back

Provider profile

SULAI, NANNA MD

Hematology-Oncology · NPI 1376864017 · TYLER, TX

1
Groups
65
Codes · 2024
84,373
Disclosed services

SULAI, NANNA is a Hematology-Oncology in TYLER, TX, a member of 1 medical group, who billed 65 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

84,373
disclosed services
65
codes billed to Medicare Part B
Prior year · CY2023 86,311 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9267 Injection, paclitaxel, 1 mg
J9299 Injection, nivolumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1756 Injection, iron sucrose, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0461 Injection, atropine sulfate, 0.01 mg
36415 Insertion of needle into vein for collection of blood sample
J1626 Injection, granisetron hydrochloride, 100 mcg
80053 Blood test, comprehensive group of blood chemicals
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
J0640 Injection, leucovorin calcium, per 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96413 Administration of chemotherapy into vein, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
J9206 Injection, irinotecan, 20 mg
J9045 Injection, carboplatin, 50 mg
J3489 Injection, zoledronic acid, 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96415 Administration of chemotherapy into vein, each additional hour
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96372 Injection of drug or substance under skin or into muscle
J3490 Unclassified drugs
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
85055 Reticulated (young) platelet measurement
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
83615 Lactate dehydrogenase (enzyme) level
J7030 Infusion, normal saline solution , 1000 cc
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
71260 Ct scan of chest with contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96523 Irrigation of implanted venous access drug delivery device
74177 Ct scan of abdomen and pelvis with contrast
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
96361 Infusion into a vein for hydration, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
96360 Infusion into a vein for hydration, 31-60 minutes
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82607 Cyanocobalamin (vitamin b-12) level
96377 Application of on-body injector for under skin injection
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96374 Injection of drug or substance into vein

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.